OVARIAN CANCER (OVCA)
Clinical trials for OVARIAN CANCER (OVCA) explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER (OVCA) trials appear
Sign up with your email to follow new studies for OVARIAN CANCER (OVCA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Pre-Surgery bootcamp aims to boost cancer surgery outcomes
Disease control Recruiting nowThis study tests a comprehensive health program (prehabilitation) given before major cancer surgery, either alone or with standard pre-surgery chemotherapy. It includes 148 frail patients with pancreatic, liver, ovarian, kidney, or bladder cancers. The goal is to see if the progr…
Matched conditions: OVARIAN CANCER (OVCA)
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 26, 2026 02:10 UTC
-
New drug KIVU-107 targets tough tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug, KIVU-107, in about 76 adults with advanced solid tumors that have not responded to standard treatments. The drug is an antibody-drug conjugate designed to deliver a cancer-killing agent directly to tumor cells. The main goal is to find the…
Matched conditions: OVARIAN CANCER (OVCA)
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for ovarian cancer: targeted drug takes on resistant tumors
Disease control Recruiting nowThis study tests a new drug, trastuzumab deruxtecan (T-DXd), in people with recurrent ovarian cancer whose tumors have stopped responding to PARP inhibitors. T-DXd targets a protein called HER2 found on some cancer cells. The trial compares T-DXd to standard chemotherapy to see w…
Matched conditions: OVARIAN CANCER (OVCA)
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 19, 2026 11:59 UTC